HK1209801A1 - Method for preventing and or treating infections, colonisations, or illnesses related to staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans and or malassezia furfur - Google Patents
Method for preventing and or treating infections, colonisations, or illnesses related to staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans and or malassezia furfurInfo
- Publication number
- HK1209801A1 HK1209801A1 HK15110375.7A HK15110375A HK1209801A1 HK 1209801 A1 HK1209801 A1 HK 1209801A1 HK 15110375 A HK15110375 A HK 15110375A HK 1209801 A1 HK1209801 A1 HK 1209801A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- colonisations
- preventing
- pseudomonas aeruginosa
- candida albicans
- streptococcus pyogenes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1262128A FR2999601B1 (fr) | 2012-12-17 | 2012-12-17 | Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis |
PCT/FR2013/053071 WO2014096641A1 (fr) | 2012-12-17 | 2013-12-13 | Méthode pour prévenir et/ou traiter les infections, colonisations ou maladies liées à staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans et/ou malassezia furfur |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1209801A1 true HK1209801A1 (en) | 2016-04-08 |
Family
ID=48128456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15110375.7A HK1209801A1 (en) | 2012-12-17 | 2015-10-22 | Method for preventing and or treating infections, colonisations, or illnesses related to staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans and or malassezia furfur |
Country Status (10)
Country | Link |
---|---|
US (2) | US20150366920A1 (pt) |
EP (1) | EP2931924B1 (pt) |
JP (1) | JP6309967B2 (pt) |
CN (1) | CN105189732B (pt) |
BR (1) | BR112015014118A2 (pt) |
CA (1) | CA2892478A1 (pt) |
ES (1) | ES2645099T3 (pt) |
FR (1) | FR2999601B1 (pt) |
HK (1) | HK1209801A1 (pt) |
WO (1) | WO2014096641A1 (pt) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2999601B1 (fr) | 2012-12-17 | 2015-01-30 | Urgo Lab | Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis |
US9653770B2 (en) | 2014-10-21 | 2017-05-16 | At&T Intellectual Property I, L.P. | Guided wave coupler, coupling module and methods for use therewith |
ITUB20153106A1 (it) * | 2015-08-13 | 2017-02-13 | Probiotical Spa | Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne |
CN105709218A (zh) * | 2016-03-18 | 2016-06-29 | 辽宁成大生物股份有限公司 | 一种奇异变形杆菌-金黄色葡萄球菌-铜绿假单胞菌吸附联合疫苗的制备方法 |
BE1024425B9 (nl) * | 2016-06-21 | 2018-03-26 | Yun NV | Dermatologische preparaten voor het onderhouden en/of herstellen van een gezonde huidmicrobiota |
IT201600081420A1 (it) * | 2016-08-03 | 2018-02-03 | Probiotical Spa | Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico |
CN107794247A (zh) * | 2016-08-31 | 2018-03-13 | 广州金羿噬菌体生物技术有限公司 | 一株痤疮丙酸杆菌噬菌体及其应用 |
CN107794232B (zh) * | 2016-08-31 | 2022-03-08 | 广州金羿噬菌体生物技术有限公司 | 拮抗痤疮丙酸杆菌和革兰氏阳性菌生长的链球菌及其代谢产物 |
EP3513799A4 (en) * | 2016-09-15 | 2020-04-29 | Kirin Holdings Kabushiki Kaisha | COMPOSITION WITH LACTIC ACID BACTERIUM AS AN ACTIVE SUBSTANCE TO PREVENT OR REDUCE SKIN CONDITION THAT IS CAUSED BY THE ABNORMAL PROLIFERATION OF A SPECIFIC BACTERIUM IN THE SKIN |
KR101846742B1 (ko) | 2016-11-26 | 2018-04-06 | (주)앰틱스바이오 | 신규한 락토바실러스 파라플란타룸 균주 및 이의 용도 |
CN107496445B (zh) * | 2017-08-25 | 2020-04-28 | 北京海洁海斯健康科技有限公司 | 一种去定植药物及其制备方法与应用 |
KR102032546B1 (ko) * | 2017-11-16 | 2019-10-15 | 씨제이제일제당 주식회사 | 락토바실러스 플란타룸 배양물을 포함하는 항균용 화장료 조성물 |
CN110680836B (zh) * | 2018-06-19 | 2021-04-02 | 景岳生物科技(中国)有限公司 | 副干酪乳杆菌菌株gmnl-653用于制备改善狐臭组合物的用途 |
CN109172613B (zh) * | 2018-08-14 | 2022-04-22 | 景岳生物科技(中国)有限公司 | 含乳杆菌死菌培养物的皮肤外用组合物及其于促进伤口愈合及降低疤痕产生的用途 |
KR102063544B1 (ko) * | 2018-09-12 | 2020-01-09 | (주)성운파마코피아 | 항진균 활성 또는 항균 활성을 갖는 락토바실러스 살리바리우스 swpm101 |
JP7045671B2 (ja) * | 2018-11-12 | 2022-04-01 | 有限会社バイオ研 | 皮膚塗布用の皮膚創傷治癒促進組成物、その製造方法、及び創傷被覆材 |
TWI700365B (zh) * | 2018-11-14 | 2020-08-01 | 弘光科技大學 | 新穎乳酸菌菌株及其用於治療或/及預防皮膚疾病之用途 |
BR112021013190A2 (pt) * | 2019-01-04 | 2021-09-28 | Lactobio A/S | Cepa bacteriana isolada, composição e uso de composição |
CN109957530B (zh) * | 2019-03-19 | 2021-12-07 | 江西仁仁健康产业有限公司 | 一种植物乳杆菌及其应用 |
CN111763630A (zh) * | 2019-03-27 | 2020-10-13 | 深圳微健康基因科技有限公司 | 表皮葡萄球菌及其用途 |
KR102063757B1 (ko) * | 2019-05-03 | 2020-01-08 | 주식회사 메디오젠 | 가드네렐라 바기날리스 및 칸디다 알비칸스에 항균 효과를 갖는 질염 치료 또는 개선용 유산균 |
CN110257306B (zh) * | 2019-07-26 | 2021-08-10 | 福建省农业科学院农业工程技术研究所 | 一株植物乳杆菌及其应用 |
KR102058622B1 (ko) | 2019-08-27 | 2019-12-23 | 주식회사 아미코스메틱 | 여드름 유발 피부상재균에 대한 항균 활성을 갖는 락토바실러스 쿠르바투스 |
KR102305609B1 (ko) * | 2019-08-27 | 2021-09-28 | 코스맥스 주식회사 | 스타필로코커스속 균주 및 그의 용도 |
US20220347229A1 (en) * | 2019-10-02 | 2022-11-03 | Biome Inc. | Staphylococcus epidermidis strain having immunity-enhancing activity and antibacterial activity against pathogenic bacteria, and use thereof |
JP2023513776A (ja) * | 2020-02-14 | 2023-04-03 | エルジー ハウスホールド アンド ヘルスケア リミテッド | 多糖類、酵母抽出物及びプロバイオティクス特性を有する菌株発酵物を有効成分として含む皮膚改善用化粧料組成物 |
KR102167387B1 (ko) * | 2020-05-14 | 2020-10-19 | 코스맥스 주식회사 | 피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물 |
KR20230047399A (ko) * | 2020-07-23 | 2023-04-07 | 킴벌리-클라크 월드와이드, 인크. | 방광 건강 개선을 위한 방광 마이크로바이옴 조절 방법 |
CN113080461A (zh) * | 2021-05-14 | 2021-07-09 | 艾兰得生物科技研究泰州有限公司 | 一种具有抑制奇异变形杆菌生长作用的益生菌及其发酵液和应用 |
CA3150903A1 (en) * | 2021-05-14 | 2022-11-14 | Xuejun Li | Probiotic for inhibiting growth of proteus mirabilis, and fermentation broth and application thereof |
KR102665552B1 (ko) * | 2021-05-28 | 2024-05-10 | 이화여자대학교 산학협력단 | 신규한 노보스핑고비움 속 균주 및 이의 용도 |
WO2023133503A2 (en) * | 2022-01-07 | 2023-07-13 | Massachusetts Institute Of Technology | Corynebacterium to treat or limit cutaneous wound infection |
CN114806977B (zh) * | 2022-06-21 | 2022-10-21 | 山东锦鲤生物工程有限公司 | 一株唾液乳杆菌及其在制备抗皮炎的产品中的应用 |
CN115181696B (zh) * | 2022-06-27 | 2023-08-29 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一种长双歧杆菌cb39Y4及其应用 |
CN115181699B (zh) * | 2022-06-28 | 2023-08-29 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一株长双歧杆菌cb20y1及其应用 |
WO2024007235A1 (en) * | 2022-07-07 | 2024-01-11 | Henkel Ag & Co. Kgaa | A method of determining whether a scalp is itchy or not, and a method of treating scalp itchiness |
CN115948275B (zh) * | 2022-09-09 | 2024-04-02 | 青岛蔚蓝生物股份有限公司 | 一株植物乳植杆菌及其在预防和治疗呼吸道疾病中的应用 |
FR3142886A1 (fr) * | 2022-12-09 | 2024-06-14 | Benu Blanc | Composition cosmetique/dermatologique |
CN116004464A (zh) * | 2023-01-06 | 2023-04-25 | 上海上药信谊药厂有限公司 | 一株植物乳杆菌及其应用 |
CN116676239B (zh) * | 2023-07-26 | 2023-10-27 | 杭州微致生物科技有限公司 | 一种植物乳杆菌vb165及其应用 |
CN116948922B (zh) * | 2023-09-20 | 2024-03-01 | 杭州微致生物科技有限公司 | 一种格氏乳杆菌vb247及其应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1723116A1 (ru) * | 1988-04-15 | 1992-03-30 | Оренбургский Государственный Медицинский Институт | Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний |
US5733568A (en) | 1993-12-03 | 1998-03-31 | Lafor Laboratories Limited | Micro-encapsulated lactobacilli for medical applications |
SE9502588L (sv) * | 1995-07-13 | 1997-01-14 | Moelnlycke Ab | Hämning av tillväxten av bakterier i samband med absorberande alster med hjälp av tillsats av andra bakterier |
ATE496989T1 (de) * | 1997-02-11 | 2011-02-15 | Entpr Ie Trd As Bioresearch Ie | Probiotische stämme des lactobacillus salivarius und daraus hergestellte antimikrobielle mittel |
US6716435B1 (en) | 1997-04-18 | 2004-04-06 | Ganeden Biotech, Inc. | Absorbent product containing absorbent structure and Bacillus coagulans |
SE511648C2 (sv) | 1998-04-17 | 1999-11-01 | Bacterum Ab | Streptokockpreparat för behandling av öroninflammation |
SE513261C2 (sv) | 1998-12-16 | 2000-08-14 | Sca Hygiene Prod Ab | Absorberande alster innefattande en synergistisk kombination av en pH-reglerande substans och mjölksyrabakterier |
ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
CA2368509A1 (en) | 1999-04-14 | 2000-10-19 | Ganeden Biotech, Inc. | Methods for inhibiting microbial infections associated with sanitary products |
DE60137235D1 (de) * | 2000-08-25 | 2009-02-12 | Wakamoto Pharma Co Ltd | L. salivarius-Stamm enthaltende probiotische Produkte |
CN100553646C (zh) | 2000-10-06 | 2009-10-28 | 雀巢产品股份有限公司 | 用乳酸菌微生态制剂调节皮肤免疫系统 |
GB0124580D0 (en) * | 2001-10-12 | 2001-12-05 | Univ Reading | New composition |
SE0104199L (sv) | 2001-12-13 | 2003-06-14 | Sca Hygiene Prod Ab | Ny produkt |
FR2848115B1 (fr) * | 2002-12-05 | 2005-03-25 | Rhodia Chimie Sa | Composition de bacteries et son utilisation |
SE525647C2 (sv) * | 2003-01-03 | 2005-03-29 | Sca Hygiene Prod Ab | Hygientissue för rengöring av och överföring av mjölksyraproducerande bakterier till huden och det urogenitila området |
US20060258596A1 (en) * | 2003-02-14 | 2006-11-16 | Walsh Timothy R | Antimicrobial agents |
ITMI20041550A1 (it) | 2004-07-29 | 2004-10-29 | Proge Farm Srl | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide |
MX2007004135A (es) | 2004-10-04 | 2007-06-15 | Oreal | Composicion cosmetica y/o dermatologica para pieles sensibles. |
EP2371373A1 (en) * | 2005-03-18 | 2011-10-05 | The United States of America as represented by the secretary of Agriculture | Bacteriocins and novel bacterial strains |
JP2010512865A (ja) * | 2006-12-19 | 2010-04-30 | フェロサン エーエス | 乳酸菌を含む創傷または組織包帯 |
CN101353633B (zh) * | 2008-06-13 | 2011-12-28 | 浙江工商大学 | Lactobacillus plantarum ZJ316、产生的抗菌肽及其制备与应用 |
CN102215849A (zh) * | 2008-11-17 | 2011-10-12 | 埃索姆股份公司 | 含有链球菌菌株和乳杆菌菌株的组合的药物制剂 |
JP6267633B2 (ja) * | 2011-05-06 | 2018-01-24 | オルガノバランス メディカル アーゲー | 新規な乳酸菌及びそれを含有する組成物 |
FR2999601B1 (fr) | 2012-12-17 | 2015-01-30 | Urgo Lab | Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis |
-
2012
- 2012-12-17 FR FR1262128A patent/FR2999601B1/fr not_active Expired - Fee Related
-
2013
- 2013-12-13 US US14/648,837 patent/US20150366920A1/en not_active Abandoned
- 2013-12-13 EP EP13818298.5A patent/EP2931924B1/fr active Active
- 2013-12-13 JP JP2015547125A patent/JP6309967B2/ja not_active Expired - Fee Related
- 2013-12-13 CA CA2892478A patent/CA2892478A1/fr not_active Abandoned
- 2013-12-13 WO PCT/FR2013/053071 patent/WO2014096641A1/fr active Application Filing
- 2013-12-13 CN CN201380065939.XA patent/CN105189732B/zh active Active
- 2013-12-13 BR BR112015014118A patent/BR112015014118A2/pt active Search and Examination
- 2013-12-13 ES ES13818298.5T patent/ES2645099T3/es active Active
-
2015
- 2015-10-22 HK HK15110375.7A patent/HK1209801A1/xx unknown
-
2017
- 2017-10-18 US US15/786,738 patent/US10449222B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2014096641A1 (fr) | 2014-06-26 |
CN105189732A (zh) | 2015-12-23 |
EP2931924B1 (fr) | 2017-10-04 |
US10449222B2 (en) | 2019-10-22 |
CA2892478A1 (fr) | 2014-06-26 |
BR112015014118A2 (pt) | 2017-07-11 |
FR2999601B1 (fr) | 2015-01-30 |
FR2999601A1 (fr) | 2014-06-20 |
ES2645099T3 (es) | 2017-12-04 |
EP2931924A1 (fr) | 2015-10-21 |
JP6309967B2 (ja) | 2018-04-11 |
JP2016508712A (ja) | 2016-03-24 |
US20180036356A1 (en) | 2018-02-08 |
US20150366920A1 (en) | 2015-12-24 |
CN105189732B (zh) | 2018-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1209801A1 (en) | Method for preventing and or treating infections, colonisations, or illnesses related to staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans and or malassezia furfur | |
IL258886A (en) | Methods for the treatment and prevention of Staphylococcus aureus infections and related conditions | |
HK1220624A1 (zh) | 抗微生物劑的組合物和製劑、它們的方法以及用於治療微生物感染的方法 | |
ZA201608604B (en) | Compositions and methods for treating and preventing staphylococcus aureus infections | |
JP2015528502A5 (pt) | ||
DK3444268T3 (da) | Staphylococcus aureus-leukocidiner, terapeutiske sammensætninger og anvendelser deraf | |
WO2012173689A3 (en) | Antimicrobial compounds and methods of making and using the same | |
EP2570411A4 (en) | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND WITH KYNURENINE PRODUCTION-INHIBITING EFFECT | |
BR112012023355A2 (pt) | composto, composição farmacêutica e método de ruptura da interação nek2/hec1 | |
EP2531025A4 (en) | METHOD FOR TREATING FUNGI FERTIONS, FUNGICIDAL COMPOSITIONS AND THEIR USE | |
EP2991483A4 (en) | ANTIMICROBIAL COMPOSITION WITH HIGH OSMOLARITY WITH ONE OR MORE ORGANIC SOLVENTS | |
EP3037090A4 (en) | Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating rheumatoid arthritis | |
EP2723396A4 (en) | ALKYLAMINOALKYLOLIGOMERS AS AN ANTIMICROBIAL BROADBAND ACTIVE | |
DK2600869T3 (da) | Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin | |
FR2954942B1 (fr) | Composition cosmetique, compose et procede de traitement cosmetique | |
HK1207981A1 (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
EP2566891A4 (en) | PASSIVE ANTI-GLUCOSAMINIDASE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS | |
EP2572721A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN INHIBITOR OF HIF-2 AS ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF ARTHRITIS | |
SI3298083T1 (sl) | Protimikrobno sredstvo za sestavek za premaz | |
FR3005472B1 (fr) | Composition pour revetement de surface isolant, antibacterien et anti-moisissure | |
EP3056552A4 (en) | Active energy-ray-curable resin composition for coating organic or inorganic substrate | |
PT2735309T (pt) | Composição farmacêutica para o tratamento da tendinite calcificada e/ou da bursite calcificada | |
HK1200364A1 (en) | Topical film-forming composition and use thereof for treating or preventing onychophagia | |
IL258683A (en) | Gel-based compositions for treating urinary tract infections | |
EP2910547A4 (en) | COMPOUND, TAUTOMER AND GEOMETRIC ISOMER THEREOF, SALT OF THE COMPOUND, THE TAUTOMER OR THE GEOMETRIC ISOMER, METHOD FOR THE PRODUCTION THEREOF, THE TAUTOMER, THE ISOMER OR THE SALT, ANTIMICROBIAL AGENT, AND MEDICAMENT AGAINST INFECTIONS |